Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites
Table 1
Baseline characteristics of patients with sepsis between the survivor and non-survivor groups.
Parameters
Survivors ()
Nonsurvivors ()
value
Age (years)
0.200
Gender, (%)
—
—
0.089
Male
94 (61.4%)
104 (70.7%)
—
Female
59 (38.6%)
43 (29.3%)
—
Comorbidities
—
—
—
Hypertension, (%)
28 (18.3%)
38 (25.9%)
0.115
Diabetes mellitus, (%)
22 (14.4%)
30 (20.4%)
0.168
Chronic lung disease, (%)
3 (2.0%)
10 (6.8%)
0.038
Cardiac disease, (%)
12 (7.8%)
16 (10.9%)
0.365
Chronic renal disease, (%)
9 (5.9%)
17 (11.6%)
0.080
Body temperature (°C)
0.124
Heart rate (per minute)
<0.001
Respiratory rate (per minute)
<0.001
Mean atrial pressure (mmHg)
0.007
Mechanical ventilation, n (%)
82 (53.6%)
105 (71.4%)
0.001
Continuous renal replacement therapy, (%)
29 (19.0%)
41 (27.9%)
0.067
Septic shock, (%)
111 (72.5%)
145 (98.6%)
<0.001
APACHE II score
<0.001
SOFA score
<0.001
GCS score
15.0 (P25 12.0-P7515.0)
7.0 (P25 3.0-P7514.0)
<0.001
Site of infection
—
—
0.004
Respiratory system, (%)
32 (20.9%)
42 (28.6%)
—
Genitourinary system, (%)
10 (6.5%)
12 (8.2%)
—
Gastrointestinal system, (%)
30 (19.6%)
27 (18.3%)
—
Bloodstream, (%)
22 (14.5%)
34 (23.1%)
—
Hepatobiliary system, (%)
0 (0.0%)
2 (1.4%)
—
Central nervous system, (%)
0 (0.0%)
2 (1.4%)
—
Unknown, (%)
59 (38.5%)
28 (19%)
—
APACHE II: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; GCS: Glasgow Coma Scale; values were calculated by chi-square test, Fisher’s exact test, Student’s -test, or Mann–Whitney test; indicates statistical significance.
